Literature DB >> 15939837

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Ronald C Kessler1, Patricia Berglund, Olga Demler, Robert Jin, Kathleen R Merikangas, Ellen E Walters.   

Abstract

CONTEXT: Little is known about lifetime prevalence or age of onset of DSM-IV disorders.
OBJECTIVE: To estimate lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the recently completed National Comorbidity Survey Replication. DESIGN AND
SETTING: Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using the fully structured World Health Organization World Mental Health Survey version of the Composite International Diagnostic Interview. PARTICIPANTS: Nine thousand two hundred eighty-two English-speaking respondents aged 18 years and older. MAIN OUTCOME MEASURES: Lifetime DSM-IV anxiety, mood, impulse-control, and substance use disorders.
RESULTS: Lifetime prevalence estimates are as follows: anxiety disorders, 28.8%; mood disorders, 20.8%; impulse-control disorders, 24.8%; substance use disorders, 14.6%; any disorder, 46.4%. Median age of onset is much earlier for anxiety (11 years) and impulse-control (11 years) disorders than for substance use (20 years) and mood (30 years) disorders. Half of all lifetime cases start by age 14 years and three fourths by age 24 years. Later onsets are mostly of comorbid conditions, with estimated lifetime risk of any disorder at age 75 years (50.8%) only slightly higher than observed lifetime prevalence (46.4%). Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.
CONCLUSIONS: About half of Americans will meet the criteria for a DSM-IV disorder sometime in their life, with first onset usually in childhood or adolescence. Interventions aimed at prevention or early treatment need to focus on youth.

Entities:  

Mesh:

Year:  2005        PMID: 15939837     DOI: 10.1001/archpsyc.62.6.593

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  2000 in total

1.  Developmental changes in resting-state functional networks among individuals with and without internalizing psychopathologies.

Authors:  Katie L Burkhouse; Jonathan P Stange; Rachel H Jacobs; Runa Bhaumik; Katie L Bessette; Amy T Peters; Natania A Crane; Kayla A Kreutzer; Kate Fitzgerald; Christopher S Monk; Robert C Welsh; K Luan Phan; Scott A Langenecker
Journal:  Depress Anxiety       Date:  2018-12-05       Impact factor: 6.505

2.  Onset, Comorbidity, and Predictors of Nicotine, Alcohol, and Marijuana Use Disorders Among North American Indigenous Adolescents.

Authors:  Dane Hautala; Kelley Sittner; Melissa Walls
Journal:  J Abnorm Child Psychol       Date:  2019-06

3.  Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients.

Authors:  Zhijun Yao; Yu Fu; Jianfeng Wu; Wenwen Zhang; Yue Yu; Zicheng Zhang; Xia Wu; Yalin Wang; Bin Hu
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

4.  The Longitudinal Associations Between Outness and Health Outcomes Among Gay/Lesbian Versus Bisexual Emerging Adults.

Authors:  Brian A Feinstein; Christina Dyar; Dennis H Li; Sarah W Whitton; Michael E Newcomb; Brian Mustanski
Journal:  Arch Sex Behav       Date:  2018-12-05

5.  Psychological Factors that Link Socioeconomic Status to Depression/Anxiety in Patients with Systemic Lupus Erythematosus.

Authors:  Desiree R Azizoddin; Geraldine Zamora-Racaza; Sarah R Ormseth; Lekeisha A Sumner; Chelsie Cost; Julia R Ayeroff; Michael H Weisman; Perry M Nicassio
Journal:  J Clin Psychol Med Settings       Date:  2017-12

6.  Cortical Functional Connectivity Evident After Birth and Behavioral Inhibition at Age 2.

Authors:  Chad M Sylvester; Christopher D Smyser; Tara Smyser; Jeanette Kenley; Joseph J Ackerman; Joshua S Shimony; Steve E Petersen; Cynthia E Rogers
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

7.  Assessing and Treating Child Anxiety in Schools.

Authors:  Matthew P Mychailyszyn; Rinad S Beidas; Courtney L Benjamin; Julie M Edmunds; Jennifer L Podell; Jeremy S Cohen; Philip C Kendall
Journal:  Psychol Sch       Date:  2011-01-11

Review 8.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

9.  Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting.

Authors:  Shubha Bhat; Miranda E Kroehl; Katy E Trinkley; Zeta Chow; Lauren J Heath; Sarah J Billups; Danielle F Loeb
Journal:  Popul Health Manag       Date:  2017-12-06       Impact factor: 2.459

10.  Not all posttraumatic stress disorder symptoms are equal: fear, dysphoria, and risk of developing hypertension in trauma-exposed women.

Authors:  Jennifer A Sumner; Laura D Kubzansky; Andrea L Roberts; Qixuan Chen; Eric B Rimm; Karestan C Koenen
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.